Key result
L-type Ca2+ channels, specifically CaV1.2, play a role in cancer cell proliferation, migration, and autophagy induction, highlighting their potential as targets for new cancer therapeutics.
This review highlights the potential of targeting CaV1.2 channels as a novel therapeutic strategy in cancer by modulating cell proliferation, migration, and autophagy.
May support CaV1.2 as cancer therapeutic target; leaves open clinical translation and safety.
Extensive research is currently underway, seeking better diagnostic methods and treatments and a better understanding of the molecular mechanisms involved in cancer, from the role of specific genetic mutations to the intricate biochemical and molecular pathways involved. Because of their role in regulating relevant physiological events such as cell proliferation, migration, and invasion, ion channels have recently been recognized as important elements in cancer initiation and progression. Moreover, it has been reported that pharmacological intervention in ion channel activity might provide protection against diverse types of cancer, and that ion channels could be used as targets to counteract tumor growth, prevent metastasis, and overcome the therapy resistance of tumor cells. In this context, Ca2+ channels have been found to play a role in tumorigenesis and tumor progression. Specifically, L-type Ca2+ channel inhibition may affect cell proliferation, differentiation, and apoptosis. This review aims to provide insights into the potential role of these channels in cancer cell lines, emphasizing their participation in cell proliferation, migration, and autophagy induction, as well as their potential as rational targets for new cancer therapeutics.
No takes yet. Share an insight, caveat, or question.
Martínez-Delgado et al. (2017) conducted a review in Cancer. CaV1.2 Channels was evaluated on Cell proliferation, migration, and autophagy induction. L-type Ca2+ channels, specifically CaV1.2, play a role in cancer cell proliferation, migration, and autophagy induction, highlighting their potential as targets for new cancer therapeutics.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: